XM does not provide services to residents of the United States of America.

Wall St indexes mixed; Nvidia earnings, Fed policy in focus



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>US STOCKS-Wall St indexes mixed; Nvidia earnings, Fed policy in focus</title></head><body>

For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.

Nvidia falls after report Blackwell chips overheating

Tesla jumps after report Trump team's could ease rules

CVS Health gains on new board appointments in Glenview deal

Indexes: Dow down 0.08%, S&P 500 up 0.10%, Nasdaq up 0.24%

Updated at 09:43 a.m. ET/1443 GMT

By Lisa Pauline Mattackal and Purvi Agarwal

Nov 18 (Reuters) - Wall Street's main indexes were mixed on Monday, as investors looked ahead to earnings from AI-chip leader Nvidia following a rout the previous week on apprehensions about Donald Trump's cabinet appointments and the central bank's policy path.

Results from Nvidia NVDA.O, which reports third-quarter earnings on Wednesday, will be crucial as investors assess if the euphoria around AI, responsiblefor much of markets' tech-driven rally this year, can be sustained. Its stock has nearly tripled in value this year.

Nvidia's shares fell 2.8%,after a report said its new AI chips were overheating in servers, weighing on the Information Technology sector .SPLRCT, which lost 0.3%.

"I'm optimistic that they're going to continue to beat, but... optimism has been so high on that particular name (Nvidia) that you can't help but see some potential for a bit of a selloff," said Robert Pavlik, senior portfolio manager at Dakota Wealth.


Meanwhile, Consumer Discretionary .SPLRCD stocks gained 1.4% after Tesla TSLA.O jumped 7.2% following a report that members of Trump's transition team were seeking to ease U.S. rules for self-driving cars. The EV-maker's gains also boosted the tech-heavy Nasdaq.

Shares of Uber UBER.N and Lyft LYFT.O fell more than 4% each.

Most megacaps edged higher, with Alphabet GOOGL.O up 0.7% and Apple AAPL.O up 0.6%.

However, healthcare stocks such as UnitedHealth UNH.N and Amgen AMGN.O weighed on the Dow.

The Dow Jones Industrial Average .DJI fell 35.21 points, or 0.08%, to 43,409.78, the S&P 500 .SPX rose 5.59 points, or 0.10%, to 5,876.21 and the Nasdaq Composite .IXIC gained 44.44 points, or 0.24%, to 18,724.56.

Rising expectations that the FederalReserve will slowits policy easing paceand uncertainty over the impact of U.S. President-elect Donald Trump's cabinet appointments led to theS&P 500 .SPX and the Nasdaq .IXIC logging theirworst weekly losses in more than two months last week.

"The market’s post-election rally tapped the brakes last week," said Chris Larkin, managing director of trading and investing at E*TRADE from Morgan Stanley, adding Nvidia’s earnings would likely dictate the market’s short-term direction.

With the key holiday shopping season set to begin, results from major retailers including Walmart WMT.N, Lowe's Companies LOW.N and Target TGT.N will be closely watched this weekto gauge the strength of the U.S. consumer.

Stock indexes have shed someof the sharp gains that followedTrump's decisive victory, but Wall Street remains fairly well placed as 2024 winds down. The benchmark index has gained nearly 3% in November and about 23% year-to-date.

A host of Federal Reserve officials are slated to speakthis week and their comments will be followed closely after Chair Jerome Powell said the Fed was in no hurry to cut rates.

Traders are pricing in a 41.6% chance the Federal Reservewill keep interest rateson hold in December, according to the CME FedWatch.

CVS Health's CVS.N shares gained 2.7% after the health insurer said it would add four new members to its board in an agreement with Glenview Capital Management.

Advancing issues outnumbered decliners by a 1.62-to-1 ratio on the NYSE, and by a 1.31-to-1 ratio on the Nasdaq.

The S&P 500 posted 12 new 52-week highs and eight new lows, while the Nasdaq Composite recorded 20 new highs and 105 new lows.


Nvidia is beating revenue estimates by smaller margins https://reut.rs/4exccl1


Reporting by Lisa Mattackal and Purvi Agarwal in Bengaluru; Editing by Pooja Desai

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.